naproxen has been researched along with Ulcer in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Blythin, DJ; Bober, LA; Chiu, PJ; Conn, DJ; Domalski, MS; Kaminski, JJ; Solomon, DM; Spitler, J; Verbiar, LL; Wong, SC | 1 |
| Afzal, O; Bawa, S; Chawla, G; Deora, GS; Kalle, AM; Kumar, S; Mulakayala, N; Rajaram, A; Rathore, V; Tonk, RK | 1 |
| Jurak, M; Przykaza, K; Wiącek, AE | 1 |
| Jastorff, J; Prevoo, M; Schöfl, R; van de Laar, MAFJ | 1 |
| Onuora, S | 1 |
| Eissa, SI; Farrag, AM; Galeel, AA | 1 |
| Bercik, P; Blackler, RW; Manko, A; Motta, JP; Surette, MG; Wallace, JL; Workentine, M | 1 |
| Bjarnason, I; Hotz-Behofsits, C; Sigthorsson, G; Simpson, R; Walley, M | 1 |
| Curran, MP; Wellington, K | 1 |
| González-Cámpora, R; Herrerías-Gutiérrez, JM; Jiménez-Sáenz, M; Linares-Santiago, E | 1 |
| Albert, J; Arulmani, U; Bolten, W; Ell, C; Fortun, P; Hawkey, CJ; Hugot, JL; Keuchel, M; Krammer, G; McAlindon, M; Rebuli, R; Schumann, S; Shonde, A; Simon, B; Toth, E; Yu, V | 1 |
| Avery, GS; Brogden, RN; Heel, RC; Pakes, GE; Speight, TM | 1 |
| Kaziro, GS | 1 |
| De Medici, A; De Siena, M; Giglio, A; Rodino', S; Sacca', N | 1 |
| Chen, M; Eaton, R; Kahn, LH | 1 |
| Cousin, F; Frappaz, A; Nicolas, JF; Pacheco, Y; Sauret, V; Vincent, L | 1 |
| Johansson, C; Rubio, C; Slezak, P; Uribe, A | 1 |
| Gyires, K; Hermecz, I; Knoll, J | 1 |
3 review(s) available for naproxen and Ulcer
| Article | Year |
|---|---|
Predictive value of gastrointestinal symptoms and patient risk factors for NSAID-associated gastrointestinal ulcers defined by endoscopy? Insights from a pooled analysis of two naproxen clinical trials.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Endoscopy; Gastrointestinal Diseases; Humans; Naproxen; Pain; Randomized Controlled Trials as Topic; Risk Factors; Ulcer | 2023 |
Delayed-release lansoprazole plus naproxen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Humans; Lansoprazole; Naproxen; Omeprazole; Ulcer | 2004 |
Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.
Topics: Adult; Animals; Arthritis, Rheumatoid; Aspirin; Cyclooxygenase Inhibitors; Diclofenac; Drug Interactions; Female; Gastric Mucosa; Gout; Humans; Ibuprofen; Indomethacin; Male; Middle Aged; Naproxen; Osteoarthritis; Pain; Phenylacetates; Platelet Aggregation; Rheumatic Diseases; Spondylitis, Ankylosing; Ulcer | 1980 |
1 trial(s) available for naproxen and Ulcer
| Article | Year |
|---|---|
Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole.
Topics: Administration, Oral; Adult; Aged; Capsule Endoscopes; Cross-Over Studies; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Humans; Intestinal Mucosa; Intestine, Small; Male; Middle Aged; Naproxen; Omeprazole; Probability; Reference Values; Risk Assessment; Ulcer | 2008 |
14 other study(ies) available for naproxen and Ulcer
| Article | Year |
|---|---|
Antiinflammatory activity of substituted 6-hydroxypyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-triones. Atypical nonsteroidal antiinflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Biological Availability; Cyclooxygenase Inhibitors; Gastrointestinal Diseases; Male; Purines; Pyrimidines; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Ulcer | 1986 |
Synthesis and pharmacological evaluation of pyrazolo[4,3-c]cinnoline derivatives as potential anti-inflammatory and antibacterial agents.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Carrageenan; Cyclooxygenase 2; Edema; Escherichia coli; Heterocyclic Compounds, 2-Ring; Inflammation; Lipid Peroxidation; Microbial Sensitivity Tests; Molecular Docking Simulation; Naproxen; Pseudomonas aeruginosa; Pyrazoles; Rats; Rats, Wistar; Staphylococcus aureus; Structure-Activity Relationship; Ulcer | 2012 |
Effect of naproxen on the model lipid membrane formed on the water-chitosan subphase.
Topics: Chitosan; Humans; Naproxen; Phospholipids; Ulcer; Water | 2023 |
Therapy: Celecoxib reduces risk of ulcer bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Double-Blind Method; Gastrointestinal Hemorrhage; Humans; Naproxen; Ulcer | 2017 |
Non-carboxylic analogues of aryl propionic acid: synthesis, anti-inflammatory, analgesic, antipyretic and ulcerogenic potential.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antipyretics; Carrageenan; Disease Models, Animal; Edema; Fever; Inflammation; Male; Mice; Naphthalenes; Naproxen; Pain; Propionates; Rats; Rats, Wistar; Ulcer | 2014 |
Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota.
Topics: Alanine; Allyl Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bile; Cell Line; Cyclooxygenase 1; Gastrointestinal Hemorrhage; Humans; Hydrogen Sulfide; Intestinal Diseases; Intestinal Mucosa; Jejunum; Membrane Proteins; Microbiota; Naproxen; Protective Agents; Rats, Wistar; Sulfides; Ulcer | 2015 |
The effects of AZD3582 [4-(nitroxy)butyl-(2S)-2-(6-methoxy-2-naphthyl) propanoate], and naproxen on key pathogenic steps in NSAID-enteropathy in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Enteritis; Intestinal Diseases; Male; Naproxen; Nitric Oxide Donors; Permeability; Rats; Rats, Sprague-Dawley; Ulcer | 2007 |
Bleeding colonic ulcer and eosinophilic colitis: a rare complication of nonsteroidal anti-inflammatory drugs.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colitis; Colonic Diseases; Eosinophilia; Female; Gastrointestinal Hemorrhage; Humans; Naproxen; Ulcer | 2006 |
Oral ulceration and neutropenia associated with naproxen.
Topics: Adult; Agranulocytosis; Arthritis, Rheumatoid; Female; Humans; Mouth Diseases; Naproxen; Neutropenia; Ulcer | 1980 |
NSAIDs-induced digestive hemorrhage and esophageal pseudotumor: a case report.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Esophageal Diseases; Esophageal Neoplasms; Gastrointestinal Hemorrhage; Humans; Male; Naproxen; Ulcer | 1995 |
Over-the-counter naproxen sodium and esophageal injury.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Esophageal Diseases; Female; Humans; Male; Naproxen; Nonprescription Drugs; Ulcer | 1997 |
[Drug-induced aphthae].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Eruptions; Female; Genital Diseases, Female; Humans; Naproxen; Piroxicam; Ulcer | 2001 |
Ulcerations of the colon associated with naproxen and acetylsalicylic acid treatment.
Topics: Aspirin; Back Pain; Colonic Diseases; Colonoscopy; Female; Gastrointestinal Hemorrhage; Humans; Middle Aged; Naproxen; Ulcer | 1986 |
1,6-Dimethyl-4-oxo-1,6,7,8,9,9a-hexahydro-4H-pyrido(1,2-a)- pyrimidine-3-carboxamide (Ch-127) protects against the intestinal damage in rats caused by two weeks' daily administration of indomethacin.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Indomethacin; Intestinal Diseases; Male; Naproxen; Pyrimidinones; Rats; Rats, Inbred Strains; Ulcer | 1987 |